We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Radcal

Download Mobile App




Medtronic Finalizes Covidien Acquisition for USD 50 Billion

By HospiMedica International staff writers
Posted on 01 Feb 2015
Print article
Medtronic (Minneapolis, MN, USA and Dublin, Ireland) completed its acquisition of Covidien (Dublin, Ireland) in lockstep with the Irish High Court’s sanctioning. The companies, both major medical manufacturers of cardiovascular devices, now exist under the name Medtronic plc, with principal executive offices now headquartered in Ireland, which has a much lower corporate tax rate than the US, allowing Medtronic to lower its tax burden. Its operational headquarters remain in Minneapolis and its chairman and CEO, Omar Ishrak, will oversee the company from Minneapolis.

The acquisition allowed the companies to combine a variety of cardiovascular product lines and services, including implantable cardiac therapies such as pacemakers and defibrillators, valves, catheter-based ablation systems, stents, and vascular and peripheral technologies.

The deal is also an opportunity to expand products and services via Covidien’s reach in emerging markets. Covidien employed about 38,000 in more than 70 countries, with 41 manufacturing facilities in 17 countries; Medtronic’s workforce was about 46,000, with 8,000 in Minneapolis. Medtronic plc now totals about 85,000 employees working in 160 countries.

“Through this combination, Medtronic is expected to generate significant free cash flow, which it will be able to deploy with greater strategic flexibility, particularly in the US,” the companies said in a joint statement. Medtronic also plans to use USD 10 billion over a decade in the US to invest in early-stage companies and fund acquisitions.

Medtronic announced in June 2014 that it planned to buy Covidien for USD 43 billion and that it agreed to a cash-and-stock deal. The final transaction totaled almost USD 50 billion. Covidien and Medtronic shares have ceased trading, being replaced by Medtronic plc shares (MDT).

Related Links:

Medtronic


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Guide Wire
E-wire

Print article

Channels

Critical Care

view channel
Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)

Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions

The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read more

Surgical Techniques

view channel
Image: New studies suggest benefit of total robotic metabolic and bariatric surgery over conventional laparoscopy (Photo courtesy of 123RF)

Total Robotic Metabolic and Bariatric Surgery Proves More Beneficial than Conventional Laparoscopy

According to the U.S. Centers for Disease Control and Prevention (CDC), 42.4% of Americans are affected by obesity. Research indicates that obesity can compromise the immune system, trigger chronic inflammation,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.